In a day marked by a rangebound trading session, the Indian stock market closed in the red as investors grappled with mixed earnings reports and global economic uncertainties. The BSE Sensex slipped 326 points to close at 64,934, while the Nifty 50 shed 82 points to end the day at 19,444.
NSE
The Nifty Bank index was among the notable losers, slipping 105 points to settle at 43,891, while the Midcap Index managed to buck the trend by rising 27 points to reach 41,010.
The top losers on the Nifty 50 were SBI Life Insurance, Bajaj Finance, Infosys, Grasim and, Nestle India. However, shares of Coal India, Eicher Motors, Hindalco, Mahindra and Mahindra (M&M), JSW Steel and BPCL were top gainers.
On the sectoral front, all sectors except PSU Bank and Realty indices ended the trade in a negative territory. The worst hit were Nifty Consumer Durables and Nifty IT indices.
One of the highlights of the trading day was Coal India, which soared to an eight-year high following a robust Q2 performance.
Eicher Motors shares closed with a 2% gain after reporting strong Q2 results. The company's robust performance was well-received by investors.
Public sector banks (PSU banks) also had a notable presence on the gainers' list, with PNB and Canara Bank emerging as top performers. Their stocks witnessed substantial buying activity.
Meanwhile, Multi Commodity Exchange (MCX) continued its upward trajectory, reaching a record high.
Sun TV and Hind Copper were among the standout performers in the market, with their stocks surging 3% and 7%, respectively, on the back of impressive earnings reports.
AU Small Finance Bank also witnessed a 3% rise in its stock price, following a positive brokerage note.
Trent, after delivering a robust Q2 performance, continued its ascent in the market, reaching a record high.
On the flip side, Page Industries erased all the gains it had made following its earnings report, falling by over 3%.
REC and PFC, on the other hand, extended their gains from Samvat 2079, with both stocks rising in the range of 1-3%.
In contrast, Glenmark Pharma faced a tough day in the market, with its stock sliding by 5% due to below-than-expected Q2 results.